YS43-22

(4S,4aS,5aS,13aS,15aS,15bR)-6-methyl-3,4,4a,5,5a,7,8,13a,15,15a,15b,16-dodecahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinoline-6-ium-14-one,chloride

21α,22-Dihydrostrychnidine

19,22-Dimethyltetracontan

SF-22 (TRPML3 activator)

7,22-dihydro-8,21-dioxa-tetranaphtho[2,1-b:1',2'-d:2'',1''-h:1''',2'''-j]cyclododecene

Ergosten-(22)-triol-(3α,5α,8α)

6-Chloro-2-phenyl-4-(piperazin-1-yl)quinoline hydrochloride

4-((Cyclohexylamino)methyl)benzoic acid hydrochloride

1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine

2-Methoxy-6-(pyrazol-1-yl)-benzonitrile

1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-

(4-Methyl-tetrahydro-furan-2-yl)-methanol

2-(1-Chloro-2-oxopropyl)-5-methoxythiophenol

N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide

4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde

N-(1-(4,5-dimethyl-6-oxo-1,6-dihydropyrimidin-2-yl)-3-(thiophen-2-yl)-1H-pyrazol-5-yl)-2-(ethylthio)benzamide